JPMORGAN CHASE & CO - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$973,976
-4.8%
134,527
-2.3%
0.00%
Q2 2023$1,022,806
+61.8%
137,659
+50.8%
0.00%
Q1 2023$632,000
+135814.0%
91,273
+101.6%
0.00%
Q4 2022$465
-100.0%
45,272
-12.9%
0.00%
Q3 2022$946,000
-67.7%
51,990
-8.8%
0.00%
Q2 2022$2,930,000
-43.4%
56,991
-19.0%
0.00%
-100.0%
Q1 2022$5,180,000
-39.7%
70,336
+17.1%
0.00%0.0%
Q4 2021$8,592,000
-84.0%
60,059
-76.8%
0.00%
-85.7%
Q3 2021$53,773,000
+215.7%
259,388
+223.3%
0.01%
+250.0%
Q2 2021$17,033,000
-79.7%
80,227
-82.6%
0.00%
-81.8%
Q1 2021$83,817,000
+226.5%
462,289
+100.8%
0.01%
+175.0%
Q4 2020$25,672,000
+66.3%
230,225
+61.0%
0.00%
+33.3%
Q3 2020$15,440,000
+842.6%
143,027
+627.9%
0.00%
Q2 2020$1,638,000
-72.2%
19,650
-95.5%
0.00%
-100.0%
Q1 2020$5,900,000
+440.8%
434,526
+58.4%
0.00%
Q4 2019$1,091,000
-22.9%
274,321
-2.7%
0.00%
Q3 2019$1,415,000
+3269.0%
282,048
+4027.7%
0.00%
Q2 2019$42,0006,8330.00%
Other shareholders
NOVAVAX INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 2,559,918$543,496,0008.72%
Foresite Capital Management I, LLC 66,810$14,184,0008.55%
Samsara BioCapital, LLC 198,600$42,165,0005.20%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 330,541$70,177,0004.54%
Foresite Capital Management II, LLC 67,373$14,304,0003.85%
Rock Springs Capital Management LP 455,000$96,601,0001.91%
DELTEC ASSET MANAGEMENT LLC 56,320$11,957,0001.65%
Parametrica Management Ltd 10,200$2,166,0001.60%
SECTORAL ASSET MANAGEMENT INC 88,450$18,779,0001.52%
TSP Capital Management Group, LLC 18,525$3,933,0001.29%
View complete list of NOVAVAX INC shareholders